why is there a semaglutide shortage 🚨 FDA Moves to Permanently Shut Down Compounded GLP-1s The FDA taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling major shift in how these The Wegovy Shortage Continues, Leaving

That's a recipe for unreliable results

Male Female Date of Birth (Optional) Month 1 2 3 4 5 6 7 8 9 10 11 12 Day 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 By subscribing to the Newsletter, I agree to the terms of use and give consent to receive promotional notifications

Holst, Wewer Albrechtsen, Gabe, Rosenkilde)

According to FDA prescribing information, nausea affects approximately 44% of patients on Wegovy (weight management dose), while vomiting, diarrhea, constipation, and abdominal pain are also common, particularly during dose escalation

Monitoring plan: A1C, weight, glucose logs, and side effects

Youll need to take extra care to avoid an infection